10th August 2020

R&D Facility Expansion

Finar’s R&D Division focuses on new product development to cater to the changing & evolving needs of our valued customers. To strengthen our R&D capabilities further; we have moved to our expanded and state-of-the-art DSIR approved R&D facility. The 5500+ sqft R&D facility comprises of Chemical Research & Development, Analytical Research & Development, Scale up & Process Engineering and Developmental Quality Assurance department with more than 20 scientists overseeing development of excipients for Injectable, Solid Oral & Topical dosage forms.

The facility is equipped with all relevant advanced instruments like HPLC, GC, GCHS FTIR, Refractometer, Polarimeter, Auto-Titrator, Rotavapors, etc. The Scale Up & Process Engineering Lab is equipped with reactors with a capacity of up to 20L ensuring smooth scale-up of complex chemistry.

10th July 2020

Finar launches a range of Health & Hygiene products

Finar has launched a range of Health & Hygiene products including Face Masks, Face Shields, Safety Goggles and Hand Sanitisers. Finar will market these products in various SKUs across the country to promote health and hygiene as we face concern and stress due to COVID 19. We are ensuring quality and affordability to make sure safety of everyone in the country. All our products will be made available through our network of stockists and distributors.

26 September 2019

Gujarat Best Employer Brand Awards 2019

Finar received the "Gujarat Best Employer Brand Award 2019" by the Employer Branding Institute which is governed by the Global Advisory Council.

13 September 2019

Finar Foundation was felicitated by the Indian Red Cross Society

The Finar Foundation was felicitated by the Indian Red Cross Society in the presence of our Honorable Governor Shri Acharya Devvrat for collecting 460 units of blood in the year 2018-19.

13 September 2019

Finar achieves another milestone!

On 2nd September 2019 we completed 21 years in the industry!

31 May 2019

Finar’s R&D division is recognized and registered with DSIR

We are proud to announce that our R&D Division is recognized and registered with the Department of Scientific & Industrial Research, Government of India. This initiative was started by the Government of India to promote industrial research and development in the country. With a commitment to this objective, we applied for and successfully defended our position in front of the DSIR dignitaries. The DSIR recognition further shows and reinforces our resolve to serve our customers through in-house product development.

22 May 2019

FINAR is now EXCiPACT certified

We proudly announce that we have been awarded an EXCiPACT GMP certificate from SGS, one of EXCIPACT’s internationally-recognised certification bodies. The certificate demonstrates that our site manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) certification standard.

03 April 2019

Finar launches its new corporate logo

We are pleased to launch our new corporate logo. Although our soul remains the same, our new logo tells a story of chemistry with innovation; customer-centricity; sustainability and responsibility which reflect the personality of today's Finar.

01 April 2019

Opening of the Kolkata Depot - A big and first announcement for the New Financial Year

We are pleased to announce the opening of our 6th depot in India in Kolkata. This will help us improve and speed up service for our customers in the Eastern region.

01 March 2019

Recognition by the GCSRA (Gujarat Corporate Social Responsibility Authority)

Finar Foundation’s honest efforts to support society and schools by teaching under privileged children was recognized as the best “Sustainable and Impactful CSR project” by the Gujarat CSR Authority. This was awarded after a rigorous audit & evaluation conducted by PwC.

01 November 2017

Opening of the Vijayawada depot

We are pleased to announce the opening of our 5th depot in Vijayawada, Andhra Pradesh. This will help us be closer to our Aquaculture customers and serve them with more speed and efficiency.

11 March 2015

Amit Maheshwari to assume responsibility as Managing Director of Finar Limited

Mr. Amit Maheshwari, Director will assume the responsibility as Managing Director of Finar Limited w.e.f 11th March 2015. The Chairman and Managing Director Mr. Girish Maheshwari was instrumental in developing and shaping the business for the past 15 years. He was very proud and happy to hand over the reins to an able and astute person such as Mr. Amit Maheshwari to provide leadership to Finar for the future. Mr. Amit Maheshwari on assuming office thanked the Chairman under whose mentorship the company has grown. He opined that he has undertaken the company in an envious position due to its performance and with his team will take it to newer heights.

03 February 2015

Prantik Mukhopadhyay joins Finar Limited as Director-Sales

Prantik Mukhopadhyay, a young and dynamic industry professional has joined Finar Limited as Director Sales (Laboratory Business). Before joining Finar, Mr. Mukhopadhyay was Director Sales of the Laboratory Business at Merck Millipore, a German multinational company and a world leader in life sciences. Mr. Mukhopadhyay has an industry experience of over 24 years and has held significant portfolios in the life sciences sector including laboratory chemicals, chromatography, clinical diagnostics, specialty chemicals, and laboratory instruments.

02 August 2014

Finar has opened a central stock point at Matoda, Ahmedabad to serve customers more efficiently

06 December 2012

Finar has opened Gujarat depot at Sarkhej, Ahmedabad to serve customers more efficiently

25 October 2012

Finar was successfully assessed and registered by Intertek for ISO 9001:2008, ISO 14001:2004 & OHSAS 18001:2007 systems

29 August 2012

Finar Chemicals Limited changed its name to Finar Limited on 29th August 2012

04 August 2012

FDA Gujarat has given manufacturing license (Form 25) to Finar Chemicals Limited through license number G/25/1970 dated 4th Aug 2012 for Manufacturing of Drugs other than specified in schedule C,C(1) and X
COA Product Catalogues Product Search Parenteral Applications
COA Product Catalogues Product Search Parenteral Applications